A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the deadliest cancers.

A new blood test has been found to detect early stage pancreatic cancer with 85% accuracy when used alongside a carbohydrate antigen 19-9 test, according to a study published Feb. 12 in Science ...

He noted that other assays studied in pancreatic cancer have only examined a handful of samples. "When they publish a second ...

Researchers at Oregon Health and Science University (OHSU) have developed a blood test called PAC-MANN, to detect pancreatic ...

The American Cancer Society estimates that 67,400 Americans will be diagnosed with pancreatic cancer this year and nearly ...

A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the ...

The Phase II eNRGy trial showed durable antitumor activity with zenocutuzumab (Bizengri) in patients with NRG1 ...

OHSU's PAC-MANN test offers a breakthrough in pancreatic cancer detection, using a small blood sample to monitor protease ...

诱导 PDAC 细胞铁死亡可降低由 ACOT8 高表达引起的吉西他滨耐药性 ：研究人员将吉西他滨与铁死亡诱导剂 erastin 联合处理细胞， 实验显示联合处理显著降低了细胞对吉西他滨的耐药性，ACOT8 表达的细胞和类器官模型的生长也受到明显抑制。这表明 ACOT8 的抗铁死亡作用是导致吉西他滨耐药的关键因素。

New blood test PAC-MANN detects pancreatic cancer early with 98% accuracy, offering hope for improved survival rates.

Jared Fischer, Ph.D., and Jose Luis Montoya Mira, Ph.D., cancer researchers at Oregon Health & Science University, have developed PAC-MANN, a test that uses a small blood sample to detect changes in ...